Quick Answer
BIOLIFE SOLUTIONS INC reported Research And Development Expense of $7.57 million for the year ending 2025.
- BIOLIFE SOLUTIONS INC showed an increase of +59.3% in Research And Development Expense from 2024 to 2025.
- This data is from BIOLIFE SOLUTIONS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), BIOLIFE SOLUTIONS INC's Research And Development Expense has grown by 2,272.6%.
- Historical annual values: Fiscal year 2025: $7.57 million | Fiscal year 2024: $4.75 million | Fiscal year 2023: $5.52 million | Fiscal year 2022: $8.67 million | Fiscal year 2021: $11.82 million | Fiscal year 2020: $6.72 million | Fiscal year 2019: $3.17 million | Fiscal year 2018: $1.30 million | Fiscal year 2017: $1.19 million | Fiscal year 2016: $2.03 million | Fiscal year 2015: $1.38 million | Fiscal year 2014: $871.1 thousand | Fiscal year 2013: $487.8 thousand | Fiscal year 2012: $463.6 thousand | Fiscal year 2011: $516.5 thousand | Fiscal year 2010: $318.9 thousand.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: